What Know About This Fund’s Pharma Stock Sale Surges
A fund’s big move out of a top-performing pharma stock can puzzle investors. Here’s a clear, practical look at what k...
Implement a cashback strategy that targets debt directly, converting rewards into meaningful reductions each month.
22,486 articlesA fund’s big move out of a top-performing pharma stock can puzzle investors. Here’s a clear, practical look at what k...
Solana is trading near $97 as traders weigh a potential move above $100 this month. Analysts point to ETF demand and ...
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Insider trading patterns at Palantir raise questions about the stock's growth path as defense sector stocks attract c...
The market is hovering around record levels, but does that mean you should sit on the sidelines? Not necessarily. Thi...
The hyperliquid policy center argues that onchain perpetual futures can improve market transparency and efficiency, e...
A May 14, 2026 filing shows Trump boosting crypto exposure by buying Coinbase and Bitcoin-related stocks, a notable m...
Bitcoin logged a fresh multi-week low as markets opened, but hype defies altcoin crash with notable gains in HYPE and...
PepsiCo beat expectations in Q1 with revenue rising 8.5% and earnings surpassing estimates. International momentum an...
AMD sits near a pivotal $420 level as first-quarter results underscore strong data-center demand and a bold AI-driven...
Investors are hearing bold predictions about rapid crypto gains. This article breaks down how such moves could happen...
Bitcoin failed to break above the 200-day moving average near $82,400 as traders weigh a pattern that CryptoQuant say...